Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling

Journal of Pharmaceutical Sciences

Volumn 96, Issue 12, 2007, Pages 3444-3456

  Fabre, Marc Antoine ^b   Fuseau, Eliane ^b   Ficheux, Herve ^a  

^a Preclinical and Pharmacokinetics Department   (France)

^b EMF Consulting   (France)

Author keywords

Clearance; Monte Carlo; Pharmacokinetics; Population pharmacokinetics; Simulations; WST11

Indexed keywords

PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; WST 11;

ARTICLE; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MONTE CARLO METHOD; NORMAL HUMAN; PHOTOTHERAPY;

EID: 38149036510     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21018     Document Type: Article

References (19)

1. Huang Z. 2005. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 4:283-293.
2. Potter MJ, Szabo SM, Sarraf D, Michels R, Schmidt-Erfurth U. 2006. Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis. Can J Ophthalmol 41:34-37.
3. Nowis D, Makowski M, Stoklosa T, Legat M, Issat T, Golab J. 2005. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochimica Polonia 52:339-352.
4. Criswell MH, Ciulla TA, Lowseth LA, Small W, Danis RP, Carson DL. 2005. Anastomic vessels remain viable after photodynamic therapy in primate models of choroidal neovascularization. Invest Ophthalmol Vis Sci 46:2168-2174.
5. 2-based photodynamic therapy induces mitochondria-dependent apoptosis in K562 cells. Acta Biochimica et Biophysica Sinica 37:488-494.
6. Nayak CS. 2005. Photodynamic therapy in dermatology. Indian J Dermatol Venereol Leprol 71:155-160.
7. Maberley DAL, Chew H, Ma P, Chang A, Hollands H, Maberley A. 2005. Comparison of photodynamic therapy and transpupillary thermotherapy for subfoveal choroidal neovascularization due to aged related macular degeneration. Can J Ophthalmol 40:378-383.
8. Al-Wailli NS, Buttler GJ, Beale J, Hamilton RW, Lee BY, Lucas P. 2005. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumour surgery and phototherapy. Med Sci Monit 11:279-289.
9. Lim JI, Flaxel CJ, LaBree L. 2006. Photodynamic therapy for choroidal neovascularisation secondary to inflammatory choroiretinal disease. Ann Acad Med 35:198-202.
10. Feigl B, L-Kitchin J, Brown B. 2005. Objective functional assessment of age-related maculopathy: a special application for the multifocal electroretinogram. Clin Exp Optom 88:304-312.
11. Guymer RH, Chong EW-T. 2006. Modifiable risk factors for age-related macular degeneration. MJA 184:455-458.
12. Bylsma GW, Guymer RH. 2005. Treatment of age-related macular degeneration. Clin Exp Optom 88:322-334.
13. Xiao Z, Hansen CB, Allen TM, Millerand GG, Moore RB. 2005. Distribution of photo sensitizers in bladder cancer spheroids: Implications for intravesical instillation of photo sensitizers for photodynamic therapy of bladder cancer. J Pharm Pharm Sci 8:536-543.
14. Embleton ML, Nair SP, Heywood W, Menon DC, Cookson BD, Wilson M. 2005. Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of staphylococcus aureus. Antimicrob Agents Chemother 49:3690-3696.
15. Waki R, Gamo S, Bessho M, Hara. M. 2005. Patterning cultured cells by visible light illumination with photo sensitizers. J Biosci Bioeng 100:331-334.
16. Nube M, Bos LP, Winkelman A. 1979. Simultaneous and consecutive administration of nutrients in parental nutrition. Am J Clin Nutr 32:1505-1510.
17. Kaul TK, Gautam PI, Narula N, Babra JK. 2002. Effects of different of 1% and 2% propofol for induction of anaesthesia in elderly patients. Indian J Anaesthesia 46:460-464.
18. Mazor O, Brandis A, Plaks V, Neumark E, Rosenbach-Belkin V, Salomon Y, Scherz A. 2005. WST11, A novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model. Am Soc Photobiol J 81:342-351.
19. Ficheux H. Determination of WST11 concentrations in monkey plasma samples collected during the study: "WST11 7-day intravenous dose-ranging-finding study in the Cynomolgus monkey". NEGMA-LERADS. Internal report.